{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T03:33:12Z","timestamp":1771299192628,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T00:00:00Z","timestamp":1573862400000},"content-version":"am","delay-in-days":319,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.dsx.2018.11.033","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T02:46:51Z","timestamp":1542077211000},"page":"596-602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prevalence of dyslipidemia and its association with cardiometabolic factors and kidney function in the adult Romanian population: The PREDATORR study"],"prefix":"10.1016","volume":"13","author":[{"given":"Simona","family":"Popa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Mota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adina","family":"Popa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Mota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romulus","family":"Timar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian","family":"Serafinceanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Cheta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Graur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolae","family":"Hancu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2018.11.033_bib1","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the national cholesterol education program (NCEP) expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment Panel III)","volume":"285","year":"2001","journal-title":"J\u00a0Am Med Assoc"},{"issue":"3","key":"10.1016\/j.dsx.2018.11.033_bib2","first-page":"336","article-title":"Prevalence of diabetes mellitus and prediabetes in the adult Romanian population: PREDATORR study","volume":"8","author":"Mota","year":"2016","journal-title":"J\u00a0Diabetes"},{"issue":"9","key":"10.1016\/j.dsx.2018.11.033_bib3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s40618-016-0470-4","article-title":"Prevalence of overweight\/obesity, abdominal obesity and metabolic syndrome and atypical cardiometabolic phenotypes in the adult Romanian population: PREDATORR study","volume":"39","author":"Popa","year":"2016","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.dsx.2018.11.033_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/13814788.2017.1324844","article-title":"Associations of smoking with cardiometabolic profile and renal function in a Romanian population-based sample from the PREDATORR cross-sectional study","volume":"23","author":"Popa","year":"2017","journal-title":"Eur J Gen Pract"},{"issue":"11","key":"10.1016\/j.dsx.2018.11.033_bib5","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s11255-015-1109-7","article-title":"Prevalence of chronic kidney disease and its association with cardio-metabolic risk factors in the adult Romanian population: the PREDATORR study","volume":"47","author":"Mo\u0163a","year":"2015","journal-title":"Int Urol Nephrol"},{"issue":"7","key":"10.1016\/j.dsx.2018.11.033_bib6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.dsx.2018.11.033_bib7","first-page":"S11","article-title":"Standards of medical care in diabetes - 2012","volume":"35","author":"American Diabetes Association","year":"2012","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.dsx.2018.11.033_bib8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.dsx.2018.11.033_bib9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1161\/hc0202.101971","article-title":"New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: projected impact on the size, sex, and age distribution of the treatment-eligible population","volume":"105","author":"Fedder","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.dsx.2018.11.033_bib10","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"KDIGO","year":"2013","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.dsx.2018.11.033_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jacl.2012.05.002","article-title":"Prevalence of lipid abnormalities in the United States: the national health and nutrition examination survey 2003-2006","volume":"6","author":"T\u00f3th","year":"2012","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.dsx.2018.11.033_bib12","first-page":"247","article-title":"Mixed dyslipidemias in primary care patients in France","volume":"8","author":"Laforest","year":"2012","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.dsx.2018.11.033_bib13","unstructured":"Wood D. Plasma lipid control in Europe. http:\/\/spo.escardio.org\/eslides\/view.aspx?eevtid=40&fp=1232. Accessed on 10 May 2018."},{"issue":"5","key":"10.1016\/j.dsx.2018.11.033_bib14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/HJR.0b013e3283383f30","article-title":"Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries","volume":"17","author":"Kotseva","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"4","key":"10.1016\/j.dsx.2018.11.033_bib15","first-page":"277","article-title":"Prevalence and control of cardiovascular risk factors in Romania cardio-zone national study","volume":"2","author":"Cinteza","year":"2007","journal-title":"M\u00e6dica J Clin Med"},{"issue":"3","key":"10.1016\/j.dsx.2018.11.033_bib16","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/HJH.0000000000001572","article-title":"Perspectives on hypertension's prevalence, treatment and control in a high cardiovascular risk East European country: data from the SEPHAR III survey","volume":"36","author":"Dorobantu","year":"2018","journal-title":"J\u00a0Hypertens"},{"issue":"1","key":"10.1016\/j.dsx.2018.11.033_bib17","first-page":"29","article-title":"Total cardiovascular risk estimation in Romania. Data from the SEPHAR study","volume":"46","author":"Dorobantu","year":"2008","journal-title":"Rom J Intern Med"},{"key":"10.1016\/j.dsx.2018.11.033_bib18","first-page":"227","article-title":"Cardiovascular risk assessment in the adult (aged 40-79 Years) Romanian population","author":"Rosu","year":"2018","journal-title":"Acta Endosc"},{"key":"10.1016\/j.dsx.2018.11.033_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/01.hjh.0000523132.85277.15","article-title":"New epidemiologic national representative survey: SEPHAR III - main results","author":"Dorobantu","year":"2017","journal-title":"J\u00a0Hypertens"},{"issue":"2","key":"10.1016\/j.dsx.2018.11.033_bib20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/ijcp.12315","article-title":"Prevalence of persistent lipid abnormalities in statin-treated patients: belgian results of the Dyslipidaemia International Study (DYSIS)","volume":"68","author":"Devroey","year":"2014","journal-title":"Int J Clin Pract"},{"issue":"9","key":"10.1016\/j.dsx.2018.11.033_bib21","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20187239","article-title":"Plasma lipid abnormalities in Pakistani population: trends, associated factors, and clinical implications","volume":"51","author":"Zaid","year":"2018","journal-title":"Braz J Med Biol Res"},{"issue":"11\u201312","key":"10.1016\/j.dsx.2018.11.033_bib22","first-page":"1033","article-title":"H-1-NMR urine metabolic profiling in type 1 diabetes mellitus","volume":"55","author":"\u015etefan","year":"2010","journal-title":"Rev Roum Chem"},{"issue":"3","key":"10.1016\/j.dsx.2018.11.033_bib23","first-page":"791","article-title":"The association of the rs1049353 polymorphism of the CNR1 gene with hypoadiponectinemia","volume":"52","author":"Dinu","year":"2011","journal-title":"Rom J Morphol Embryol"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118304995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118304995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:05:10Z","timestamp":1761728710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402118304995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1871402118304995"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2018.11.033","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of dyslipidemia and its association with cardiometabolic factors and kidney function in the adult Romanian population: The PREDATORR study","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2018.11.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}